Congenital Right-Sided Diaphragmatic Hernia: Some Difficulties in Differential Diagnosis and Operative Repair [PDF]
Ronald Belsey, John Apley
openalex +1 more source
Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts +8 more
wiley +1 more source
The operative treatment of suppurative meningitis with especial reference to irrigation of the cranial and spinal subarachnoid spaces; and the importance of protective meningitis from a prognostic and therapeutic standpoint, with an analysis of the cases of recoveryndashexclusive of meningococcicndashreported in the literature [PDF]
Wells P. Eagleton
openalex +1 more source
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira +14 more
wiley +1 more source
Association between operative time and short-term postoperative complications following minimally invasive surgery for stage III-IV endometriosis. [PDF]
Yagur Y +11 more
europepmc +1 more source
This real‐world study of ROS1+ NSCLC highlights fusion diversity, treatment outcomes with crizotinib and lorlatinib, and in vitro experiments with resistance mechanisms. G2032R drives strong resistance to ROS1‐targeted TKIs, especially lorlatinib. Fusion partner location does not affect overall survival to crizotinib or lorlatinib. Findings support the
Fenneke Zwierenga +8 more
wiley +1 more source
THE NON-OPERATIVE TREATMENT OF SURGICAL TUBERCULOSIS. [PDF]
Henry Gauvain
openalex +1 more source
A bioinformatics screen identifies TCF19 as an aggressiveness‐sustaining gene in prostate cancer
Gene expression meta‐analysis in multiple prostate cancer patient cohorts identifies Transcription factor 19 (TCF19) as an aggressiveness‐sustaining gene with prognostic potential. TCF19 is a gene repressed by androgen signaling that sustains core cancer‐related processes such as vascular permeability or tumor growth and metastasis.
Amaia Ercilla +15 more
wiley +1 more source
Perioperative leukocyte-plateletcrit shift as a prognostic signature in glioblastoma. [PDF]
Krupa P +5 more
europepmc +1 more source
Ueber operative und nicht operative Behandlung entzündlicher, insbesondere eitriger Adnexerkrankungen1) [PDF]
Otto von Franqué
openalex +1 more source

